| Year |
Citation |
Score |
| 2022 |
Chang HY, Kitchen C, Bishop MA, Shermock KM, Gudzune KA, Kharrazi H, Weiner JP. Claims-based pharmacy markers for comprehensive medication management program case identification: Validation against concurrent and prospective healthcare costs and utilization. Research in Social & Administrative Pharmacy : Rsap. PMID 35550347 DOI: 10.1016/j.sapharm.2022.04.006 |
0.686 |
|
| 2022 |
Kitchen CA, Chang HY, Bishop MA, Shermock KM, Kharrazi H, Weiner JP. Comparing and validating medication complexity from insurance claims against electronic health records. Journal of Managed Care & Specialty Pharmacy. 28: 473-484. PMID 35332787 DOI: 10.18553/jmcp.2022.28.4.473 |
0.696 |
|
| 2021 |
Bishop MA, Chang HY, Kitchen C, Weiner JP, Kharrazi H, Shermock KM. Development of measurable criteria to identify and prioritize patients for inclusion in comprehensive medication management programs within primary care settings. Journal of Managed Care & Specialty Pharmacy. 27: 1009-1018. PMID 34337988 DOI: 10.18553/jmcp.2021.27.8.1009 |
0.716 |
|
| 2020 |
Chang HY, Kan HJ, Shermock KM, Alexander GC, Weiner JP, Kharrazi H. Integrating E-Prescribing and Pharmacy Claims Data for Predictive Modeling: Comparing Costs and Utilization of Health Plan Members Who Fill Their Initial Medications with Those Who Do Not. Journal of Managed Care & Specialty Pharmacy. 26: 1282-1290. PMID 32996394 DOI: 10.18553/jmcp.2020.26.10.1282 |
0.696 |
|
| 2020 |
Shermock KM. Questionable impact of Universal Medication Schedule. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 32729613 DOI: 10.1093/Ajhp/Zxaa235 |
0.332 |
|
| 2020 |
Smith AJF, Ahern SP, Shermock KM, Feller TT, Hill JD. Assessment of impact of daily huddles and visual displays on medication delivery timeliness in a large academic medical center. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 32620969 DOI: 10.1093/Ajhp/Zxaa210 |
0.36 |
|
| 2020 |
Segal JB, Apfel A, Brotman DJ, Shermock KM, Clark JM. Evaluation of Bedside Delivery of Medications Before Discharge: Effect on 30-Day Readmission. Journal of Managed Care & Specialty Pharmacy. 26: 296-304. PMID 32105180 DOI: 10.18553/Jmcp.2020.26.3.296 |
0.387 |
|
| 2019 |
Yun R, Sciubba DM, Lewin J, Streiff MB, Haut ER, Lau BD, Shermock KM, Kraus PS, Popoola VO, Dalpoas SE. Defects in processes of care for pharmacologic prophylaxis are common among neurosurgery patients who develop in-hospital, post-operative venous thromboembolism (VTE). World Neurosurgery. PMID 31698120 DOI: 10.1016/J.Wneu.2019.10.163 |
0.305 |
|
| 2019 |
Tolonen HM, Airaksinen MS, Ruokoniemi P, Hämeen-Anttila K, Shermock KM, Kurki P. Medication safety risks to be managed in national implementation of automatic substitution of biological medicines: a qualitative study. Bmj Open. 9: e032892. PMID 31662405 DOI: 10.1136/Bmjopen-2019-032892 |
0.347 |
|
| 2018 |
Merola D, Yong C, Noga SJ, Shermock KM. Costs Associated with Productivity Loss Among U.S. Patients Newly Diagnosed with Multiple Myeloma Receiving Oral Versus Injectable Chemotherapy. Journal of Managed Care & Specialty Pharmacy. 24: 1019-1026. PMID 30247101 DOI: 10.18553/Jmcp.2018.24.10.1019 |
0.349 |
|
| 2017 |
Chang HY, Richards TM, Shermock KM, Elder Dalpoas S, J Kan H, Alexander GC, Weiner JP, Kharrazi H. Evaluating the Impact of Prescription Fill Rates on Risk Stratification Model Performance. Medical Care. PMID 29036011 DOI: 10.1097/Mlr.0000000000000825 |
0.673 |
|
| 2017 |
Conway S, Brotman D, Pinto B, Merola D, Feldman L, Miller R, Shermock K. Impact of Displaying Inpatient Pharmaceutical Costs at the Time of Order Entry: Lessons From a Tertiary Care Center. Journal of Hospital Medicine. 12: 639-645. PMID 28786430 DOI: 10.12788/Jhm.2779 |
0.394 |
|
| 2017 |
Tyynismaa L, Honkala A, Airaksinen M, Shermock KM, Lehtonen L. Identifying High-alert Medications in a University Hospital by Applying Data From the Medication Error Reporting System. Journal of Patient Safety. PMID 28574956 DOI: 10.1097/Pts.0000000000000388 |
0.39 |
|
| 2016 |
Streiff MB, Lau BD, Hobson DB, Kraus PS, Shermock KM, Shaffer DL, Popoola VO, Aboagye JK, Farrow NA, Horn PJ, Shihab HM, Pronovost PJ, Haut ER. The Johns Hopkins Venous Thromboembolism Collaborative: Multidisciplinary team approach to achieve perfect prophylaxis. Journal of Hospital Medicine. 11: S8-S14. PMID 27925423 DOI: 10.1002/Jhm.2657 |
0.376 |
|
| 2016 |
Piechowski KL, Elder S, Efird LE, Haut ER, Streiff MB, Lau BD, Kraus PS, Rand CS, Popoola VO, Hobson DB, Farrow NE, Shaffer D, Shermock KM. Prescriber knowledge and attitudes regarding non-administration of prescribed pharmacologic venous thromboembolism prophylaxis. Journal of Thrombosis and Thrombolysis. PMID 27209202 DOI: 10.1007/S11239-016-1378-8 |
0.341 |
|
| 2016 |
Seal BS, Anderson S, Shermock KM. Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer. Journal of Managed Care & Specialty Pharmacy. 22: 227-35. PMID 27003552 DOI: 10.18553/Jmcp.2016.22.3.227 |
0.364 |
|
| 2015 |
Tandon S, Chew M, Eklu-Gadegbeku CK, Shermock KM, Morisky DE. Validation and psychometric properties of the 8-item Morisky Medication Adherence Scale (MMAS-8) in Type 2 diabetes patients in sub-Saharan Africa. Diabetes Research and Clinical Practice. PMID 26515909 DOI: 10.1016/J.Diabres.2015.10.001 |
0.322 |
|
| 2015 |
Lau BD, Haut ER, Hobson DB, Kraus PS, Maritim C, Austin JM, Shermock KM, Maheshwari B, Allen PX, Almario A, Streiff MB. ICD-9 Code-Based Venous Thromboembolism Performance Targets Fail to Measure Up. American Journal of Medical Quality : the Official Journal of the American College of Medical Quality. PMID 25900895 DOI: 10.1177/1062860615583547 |
0.324 |
|
| 2015 |
Seal B, Sullivan SD, Ramsey S, Asche CV, Shermock KM, Sarma S, Zagadailov E, Farrelly E, Eaddy M. Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting. Future Oncology (London, England). 11: 439-47. PMID 25675125 DOI: 10.2217/Fon.14.242 |
0.338 |
|
| 2015 |
Wong A, Kraus PS, Lau BD, Streiff MB, Haut ER, Hobson DB, Shermock KM. Patient preferences regarding pharmacologic venous thromboembolism prophylaxis. Journal of Hospital Medicine. 10: 108-11. PMID 25418208 DOI: 10.1002/Jhm.2282 |
0.4 |
|
| 2015 |
Zagadailov E, Seal BS, Shermock K, Asche CV, Chang J, Kreilick C, Yao J, Cameron J, Morland K, Eaddy M. Evaluating patterns of care in the treatment of bladder cancer with and without metastases. Journal of Clinical Oncology. 33: e15510-e15510. DOI: 10.1200/Jco.2015.33.15_Suppl.E15510 |
0.309 |
|
| 2015 |
Seal BS, Shermock K, Asche CV, Chang J, Tangirala M, Kish JK, Zagadailov E, Eaddy M. Adherence to chemotherapy guidelines for non-metastatic (NM) and metastatic (M) colorectal cancer (CRC). Journal of Clinical Oncology. 33: e14690-e14690. DOI: 10.1200/Jco.2015.33.15_Suppl.E14690 |
0.349 |
|
| 2015 |
Shermock K, Asche C, Seal B, Kreilick C, Chang J, Zagadailov E, Kish J, Eaddy M, Xia F. Cost of Care for Gastric Cancer In Patients With and Without Metastases Value in Health. 18: A201. DOI: 10.1016/J.Jval.2015.03.1165 |
0.328 |
|
| 2014 |
Pherson EC, Shermock KM, Efird LE, Gilmore VT, Nesbit T, LeBlanc Y, Brotman DJ, Deutschendorf A, Swarthout MD. Development and implementation of a postdischarge home-based medication management service. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 71: 1576-83. PMID 25174018 DOI: 10.2146/Ajhp130764 |
0.317 |
|
| 2014 |
Seal B, Sullivan SD, Ramsey SD, Asche CV, Shermock K, Sarma S, Zagadailov EA, Farrelly E, Eaddy M. Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases. Applied Health Economics and Health Policy. 12: 547-57. PMID 25005491 DOI: 10.1007/S40258-014-0101-1 |
0.314 |
|
| 2014 |
Haut ER, Garcia LJ, Shihab HM, Brotman DJ, Stevens KA, Sharma R, Chelladurai Y, Akande TO, Shermock KM, Kebede S, Segal JB, Singh S. The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis. Jama Surgery. 149: 194-202. PMID 24195920 DOI: 10.1001/Jamasurg.2013.3970 |
0.3 |
|
| 2014 |
Seal BS, Sullivan SD, Ramsey SD, Shermock KM, Ren J, Kreilick C, Boklage S, Valluri S, Sarma S, Asche CV. Systemic therapy for colorectal cancer: patterns of chemotherapy and biologic therapy use in nationally representative US claims database. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 28: 229-36. PMID 24142235 DOI: 10.1007/S40259-013-0073-Y |
0.313 |
|
| 2014 |
Serritella A, Lau BD, Haut ER, Kraus PS, Hobson D, Shaffer D, Popoola VO, Shermock K, Lanzkron S, Streiff MB. An Analysis of VTE Prophylaxis Practice in Oncology Patients after Implementation of a Standardized Mandatory Computerized Clinical Decision Support Tool Blood. 124: 4859-4859. DOI: 10.1182/Blood.V124.21.4859.4859 |
0.35 |
|
| 2013 |
Seal BS, Sullivan SD, Ramsey S, Shermock KM, Ren J, Kreilick C, Foltz Boklage SH, Valluri S, Sarma S, Asche CV. Medical costs associated with use of systemic therapy in adults with colorectal cancer. Journal of Managed Care Pharmacy : Jmcp. 19: 461-7. PMID 23806060 DOI: 10.18553/Jmcp.2013.19.6.461 |
0.388 |
|
| 2013 |
Kebede S, Prakasa KR, Shermock K, Shihab HM, Brotman DJ, Sharma R, Chelladurai Y, Haut ER, Singh S, Segal JB. A systematic review of venous thromboembolism prophylaxis strategies in patients with renal insufficiency, obesity, or on antiplatelet agents. Journal of Hospital Medicine. 8: 394-401. PMID 23761111 DOI: 10.1002/Jhm.2047 |
0.321 |
|
| 2013 |
Zeidan AM, Streiff MB, Lau BD, Ahmed SR, Kraus PS, Hobson DB, Carolan H, Lambrianidi C, Horn PB, Shermock KM, Tinoco G, Siddiqui S, Haut ER. Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events. American Journal of Hematology. 88: 545-9. PMID 23553743 DOI: 10.1002/Ajh.23450 |
0.339 |
|
| 2013 |
Seal BS, Kreilick C, Boklage SH, Shermock KM, Asche CV. Treatment patterns and cost for colorectal cancer by line of therapy and metastasis status. Journal of Clinical Oncology. 31: e14658-e14658. DOI: 10.1200/Jco.2013.31.15_Suppl.E14658 |
0.352 |
|
| 2013 |
Seal B, Valderrama A, Shermock K, Kreilick C, Boklage S, Asche C. Treatment Patterns And Cost Of Care By Lines Of Treatment For Colorectal Cancer In The Optum Oncology Research Database Value in Health. 16: A135. DOI: 10.1016/J.Jval.2013.03.658 |
0.305 |
|
| 2012 |
Carter KL, Streiff MB, Ross PA, Wellman JC, Thomas ML, Kraus PS, Shermock KM. Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The Johns Hopkins Hospital. Journal of Thrombosis and Thrombolysis. 34: 437-45. PMID 22865256 DOI: 10.1007/S11239-012-0781-Z |
0.36 |
|
| 2012 |
Lewin JJ, Ledroux SN, Shermock KM, Thompson CB, Goodwin HE, Mirski EA, Gill RS, Mirski MA. Validity and reliability of the Johns Hopkins Adapted Cognitive Exam for critically ill Patients Critical Care Medicine. 40: 139-144. PMID 21926576 DOI: 10.1097/Ccm.0B013E31822Ef9Fc |
0.312 |
|
| 2012 |
Shermock KM, Sullivan SD, Ramsey SD, Seal BS. Provider mix and costs associated with treatment of patients with bone metastases secondary to prostate cancer. Journal of Clinical Oncology. 30: e15175-e15175. DOI: 10.1200/Jco.2012.30.15_Suppl.E15175 |
0.34 |
|
| 2012 |
Lau BD, Haut ER, Maheshwari B, Kraus PS, Hobson D, Carolan H, Shermock K, Almario A, Maritim C, Streiff MB. Hospital-Acquired Venous Thromboembolism (VTE): A Retrospective Consecutive Case Series Blood. 120: 4280-4280. DOI: 10.1182/Blood.V120.21.4280.4280 |
0.383 |
|
| 2012 |
Lau BD, Haut ER, Maheshwari B, Almario A, Maritim C, Hobson D, Kraus PS, Shermock K, Carolan H, Streiff MB. Hospital-Acquired DVT/PE As “Never Events”: A Misguided Strategy for Performance Improvement in VTE Prevention. Blood. 120: 3180-3180. DOI: 10.1182/Blood.V120.21.3180.3180 |
0.352 |
|
| 2012 |
Seal B, Sullivan S, Ramsey S, Asche C, Shermock K, Sarma S, Farrelly E, Eaddy M. PCN54 Evaluating the Inpatient Hospitalization Costs of Treating Prostate Cancer Patients Value in Health. 15: A217. DOI: 10.1016/J.Jval.2012.03.1171 |
0.316 |
|
| 2012 |
Seal B, Ramsey S, Asche C, Sarma S, Sullivan S, Shermock K. PCN53 Patterns of Care and Costs Associated With Treatment of Patients With Bone Metastases Secondary to Prostate Cancer Value in Health. 15: A217. DOI: 10.1016/J.Jval.2012.03.1170 |
0.315 |
|
| 2012 |
Valluri S, Sullivan SD, Ramsey S, Asche C, Shermock K, Sarma S, Kreilick C, Foltz-Boklage S, Seal B. PCN47 Medical Expenditures Associated With the Use of Systemic Therapy for Colorectal Cancer in Privately Insured Adults in a Claims Database in the United States Value in Health. 15. DOI: 10.1016/J.Jval.2012.03.1164 |
0.326 |
|
| 2011 |
Zeidan AM, Streiff MB, Ahmed S, Kraus PS, Hobson D, Horn PB, Shermock K, Tinoco G, Haut ER. Impact of a Venous Thromboembolism Prophylaxis “Smart Orderset”: Improved Compliance, Fewer Events Blood. 118: 172-172. DOI: 10.1182/Blood.V118.21.172.172 |
0.356 |
|
| 2008 |
Biscup-Horn PJ, Streiff MB, Ulbrich TR, Nesbit TW, Shermock KM. Impact of an inpatient anticoagulation management service on clinical outcomes Annals of Pharmacotherapy. 42: 777-782. PMID 18460587 DOI: 10.1345/Aph.1L027 |
0.356 |
|
| 2008 |
Shermock KM, Horn E, Rice TL. Erythropoietic agents for anemia of critical illness. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 65: 540-6. PMID 18319499 DOI: 10.2146/Ajhp070225 |
0.338 |
|
| 2008 |
Nkansah NT, Brewer JM, Connors R, Shermock KM. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 65: 145-9. PMID 18192260 DOI: 10.2146/Ajhp070012 |
0.344 |
|
| 2003 |
Shen B, Shermock KM, Fazio VW, Achkar JP, Brzezinski A, Bevins CL, Bambrick ML, Remzi FH, Lashner BA. A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis. The American Journal of Gastroenterology. 98: 2460-7. PMID 14638349 DOI: 10.1016/S0002-9270(03)00716-0 |
0.315 |
|
| 2003 |
Gildea TR, Shermock KM, Singer ME, Stoller JK. Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency. American Journal of Respiratory and Critical Care Medicine. 167: 1387-92. PMID 12574076 DOI: 10.1164/Rccm.200209-1035Oc |
0.302 |
|
| 2002 |
Fuller MA, Shermock KM, Secic M, Laich JS, Durkin MB. Service use and costs among VA patients with schizophrenia taking risperidone or olanzapine. Psychiatric Services (Washington, D.C.). 53: 855-60. PMID 12096169 DOI: 10.1176/Appi.Ps.53.7.855 |
0.321 |
|
| 2002 |
Shermock K, Shen B, Lashner B, Achkar J. Pgi8 A Cost Analysis Of Diagnostic And Treatment Strategies In Patients With Symptoms Of Pouchitis Value in Health. 5: 253. DOI: 10.1016/S1098-3015(10)61129-1 |
0.302 |
|
| 2001 |
Nesbit TW, Shermock KM, Bobek MB, Capozzi DL, Flores PA, Leonard MC, Long JK, Militello MA, White DA, Barone LD, Goldman MP, Kvancz DA. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 58: 784-90. PMID 11351918 DOI: 10.1093/Ajhp/58.9.784 |
0.362 |
|
| 2001 |
Shermock KM, Sadik MK, Kozma CM, Sesti A, Reeder CE. Risperidone, Haloperidol and Clozapine in the South Carolina Medicaid Program A Comparative Analysis of Utilisation and Expenditure Disease Management & Health Outcomes. 9: 203-213. DOI: 10.2165/00115677-200109040-00003 |
0.342 |
|
| 2001 |
Shermock K, Fuller M, Secic M, Laich J, Durkin M. Pmh9: Health Care Utilization And Costs In Schizophrenic Patients Taking Risperidone Versus Olanzapine In A Veterans Administration Population Value in Health. 4: 142. DOI: 10.1046/J.1524-4733.2001.40202-195.X |
0.385 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1999 |
Younossi ZM, Singer ME, Mchutchison JG, Shermock KM. Cost effectiveness of Interferon α2b combined with ribavirin for the treatment of chronic hepatitis C Hepatology. 30: 1318-1324. PMID 10534357 DOI: 10.1002/Hep.510300518 |
0.3 |
|
| 2013 |
Seal B, Valderrama A, Xia F, Shermock K, Asche C. Health care costs in patients with bone metastasis secondary to prostate cancer compared to prostate cancer patients without bone metastasis in the optum oncology research database Value in Health. 16: A190. DOI: 10.1016/J.Jval.2013.03.956 |
0.299 |
|
| 2015 |
Seal B, Shermock K, Asche C, Chang J, Kreilick C, Yao J, Cameron J, Morland K, Zagadailov E, Eaddy M. Evaluating the Cost of Treating Bladder Cancer With and Without Metastases Value in Health. 18: A201. DOI: 10.1016/J.Jval.2015.03.1164 |
0.298 |
|
| 2007 |
Biscup-Horn PJ, Streiff MB, Ulbrich TR, Nesbit TW, Shermock KM. Clinical and economic benefits of an anticoagulation management service (AMS) for cardiac surgery patients Journal of Thrombosis and Thrombolysis. 25: 129-129. DOI: 10.1007/S11239-007-0114-9 |
0.298 |
|
| 2016 |
Popoola VO, Lau BD, Shihab HM, Farrow NE, Shaffer DL, Hobson DB, Kulik SV, Zaruba PD, Shermock KM, Kraus PS, Pronovost PJ, Streiff MB, Haut ER. Patient Preferences for Receiving Education on Venous Thromboembolism Prevention - A Survey of Stakeholder Organizations. Plos One. 11: e0152084. PMID 27031330 DOI: 10.1371/Journal.Pone.0152084 |
0.297 |
|
| 2009 |
Fuller M, Shermock K, Russo P, Secic M, Dirani R, Vallow S, Flanders S. Hospitalisation and resource utilisation in patients with schizophrenia following initiation of risperidone long-acting therapy in the Veterans Affairs Healthcare System. Journal of Medical Economics. 12: 317-324. PMID 19817665 DOI: 10.3111/13696990903303902 |
0.295 |
|
| 2011 |
Shermock KM, Streiff MB, Pinto BL, Kraus P, Pronovost PJ. Novel analysis of clinically relevant diagnostic errors in point-of-care devices. Journal of Thrombosis and Haemostasis : Jth. 9: 1769-75. PMID 21752186 DOI: 10.1111/J.1538-7836.2011.04439.X |
0.294 |
|
| 2010 |
Shermock KM, Clarke W, Streiff MB. A superior method to report clinically relevant quality information about the point-of-care INR device performance compared with the International Organization for Standardization guidelines Clinica Chimica Acta. 411: 1756-1760. PMID 20667446 DOI: 10.1016/J.Cca.2010.07.023 |
0.291 |
|
| 2013 |
Brotman DJ, Shihab HM, Prakasa KR, Kebede S, Haut ER, Sharma R, Shermock K, Chelladurai Y, Singh S, Segal JB. Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: a systematic review and meta-analysis. Jama Surgery. 148: 675-86. PMID 23754086 DOI: 10.1001/Jamasurg.2013.72 |
0.289 |
|
| 2015 |
Kish JK, Seal BS, Shermock K, Asche CV, Chang J, Xia F, Zagadailov E, Eaddy M. Adherence to guideline-recommended chemotherapy in the treatment of gastric cancer. Journal of Clinical Oncology. 33: e15009-e15009. DOI: 10.1200/Jco.2015.33.15_Suppl.E15009 |
0.288 |
|
| 2008 |
Shermock K, Lavallee D, Conner J, Fink J, Bragg L. Pcv76 Longitudinal Assessment Of The Clinical Utility Of Point-Of-Care Measurement Devices For Determining The International Normalized Ratio Value in Health. 11. DOI: 10.1016/S1098-3015(10)70662-8 |
0.288 |
|
| 2012 |
Seal B, Sullivan S, Ramsey S, Asche C, Shermock K, Sarma S, Farrelly E, Eaddy M. PCN51 Comparing the Use and Cost of Radiopharmaceuticals in Prostate Cancer Patients With and Without Bone Metastasis Value in Health. 15: A216. DOI: 10.1016/J.Jval.2012.03.1168 |
0.287 |
|
| 2015 |
Shermock K, Seal BS, Asche CV, Chang J, Xia F, Kish JK, Zagadailov E, Eaddy M. Surgical, radiological, and chemotherapy treatment patterns for non-metastatic and metastatic gastric cancer. Journal of Clinical Oncology. 33: e15010-e15010. DOI: 10.1200/Jco.2015.33.15_Suppl.E15010 |
0.284 |
|
| 2015 |
Seal B, Shermock K, Asche C, Kreilick C, Tangirala M, Cameron J, Kish J, Zagadailov E, Eaddy M. Patterns of Care In The Workup And Management of Non-Metastatic And Metastatic Colorectal Cancer Value in Health. 18: A191. DOI: 10.1016/J.Jval.2015.03.1107 |
0.282 |
|
| 2012 |
Gilmore JW, Haislip S, Szabo S, Sullivan SD, Ramsey SD, Kreilick C, Boklage SHF, Sarma S, Asche CV, Shermock KM, Sun K, Valluri S, Seal BS. Survival benefits of second-line chemotherapy in metastatic castrate-resistant prostate cancer (CRPC) in a southeastern oncology community practice. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E15183 |
0.282 |
|
| 2005 |
Shermock KM, Horn E, Lipsett PA, Pronovost PJ, Dorman T. Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients Critical Care Medicine. 33: 497-503. PMID 15753738 DOI: 10.1097/01.Ccm.0000155988.78188.Ee |
0.281 |
|
| 2010 |
Shermock K, Streiff M, Kraus P, Pinto B, Lavallee D. Pcv14 Comparative Effectiveness Analysis Identifies A Superior Point Of Care Device For Assessing The International Normalized Ratio Value in Health. 13. DOI: 10.1016/S1098-3015(10)72735-2 |
0.28 |
|
| 2002 |
Shermock KM, Bragg L, Connor JT, Fink J, Mazzoli G, Kottke-Marchant K. Differences in warfarin dosing decisions based on international normalized ratio measurements with two point-of-care testing devices and a reference laboratory measurement. Pharmacotherapy. 22: 1397-404. PMID 12432965 DOI: 10.1592/Phco.22.16.1397.33699 |
0.28 |
|
| 2013 |
Chelladurai Y, Stevens KA, Haut ER, Brotman DJ, Sharma R, Shermock KM, Kebede S, Singh S, Segal JB. Venous thromboembolism prophylaxis in patients with traumatic brain injury: a systematic review. F1000research. 2: 132. PMID 25309725 DOI: 10.12688/F1000Research.2-132.V1 |
0.279 |
|
| 2019 |
Aggarwal MV, Jarrell AS, Gilmore VT, Aboagye JK, Haut ER, Hobson DB, Lau BD, Kickler T, Kraus PS, Shaffer DL, Shermock KM, Streiff MB, Zheng G, Kruer RM. Anti-Xa activity by weight in critically ill patients receiving unfractionated heparin for venous thromboembolism prophylaxis. Journal of Critical Care. 52: 180-185. PMID 31078999 DOI: 10.1016/J.Jcrc.2019.04.027 |
0.276 |
|
| 2016 |
Yun R, Lewin J, Sciubba D, Haut E, Streiff M, Lau B, Shermock K, Dalpoas SE. 618: CHARACTERIZATION OF PERIOPERATIVE VENOUS THROMBOEMBOLIC EVENTS IN NEUROSURGERY PATIENTS. Critical Care Medicine. 44: 231. PMID 27850257 DOI: 10.1097/01.Ccm.0000509295.33345.A1 |
0.276 |
|
| 2004 |
Hood R, Shermock KM, Emerman C. A prospective, randomized pilot evaluation of topical triple antibiotic versus mupirocin for the prevention of uncomplicated soft tissue wound infection. The American Journal of Emergency Medicine. 22: 1-3. PMID 14724869 DOI: 10.1016/J.Ajem.2003.09.009 |
0.276 |
|
| 2003 |
Fuller MA, Shermock KM, Secic M, Grogg AL. Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine. Pharmacotherapy. 23: 1037-43. PMID 12921249 DOI: 10.1592/Phco.23.8.1037.32876 |
0.275 |
|
| 2012 |
Shermock KM, Kraus P, Streiff MB. Novel analysis of clinically relevant diagnostic errors in point-of-care devices: A reply to a rebuttal Journal of Thrombosis and Haemostasis. 10: 1192-1194. DOI: 10.1111/J.1538-7836.2012.04721.X |
0.275 |
|
| 2014 |
Newman MJ, Kraus PS, Shermock KM, Lau BD, Haut ER, Hobson DB, Streiff MB. Nonadministration of thromboprophylaxis in hospitalized patients with HIV: a missed opportunity for prevention? Journal of Hospital Medicine. 9: 215-20. PMID 24464775 DOI: 10.1002/Jhm.2156 |
0.275 |
|
| 2012 |
Shermock KM, Streiff MB, Pinto BL, Kraus P, Pronovost PJ. Novel analysis of clinically relevant diagnostic errors in point-of-care devices: a reply to a rebuttal: Letters to the Editor Journal of Thrombosis and Haemostasis. 10: 1192-1194. DOI: 10.1111/J.1538-7836.2011.04587.X |
0.274 |
|
| 2005 |
Shermock KM, Gildea TR, Singer M, Stoller JK. Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysis. Copd. 2: 411-8. PMID 17147006 DOI: 10.1080/15412550500346469 |
0.273 |
|
| 2014 |
Seal B, Anderson S, Cameron J, Shermock K. Comparison of Adherence Rates Between Oral Capecitabine and Intravenous Chemotherapy Regimens to Treat Metastatic Colon Cancer Value in Health. 17: A92. DOI: 10.1016/J.Jval.2014.03.533 |
0.273 |
|
| 2002 |
Vargo JJ, Zuccaro G, Dumot JA, Shermock KM, Morrow JB, Conwell DL, Trolli PA, Maurer WG. Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial. Gastroenterology. 123: 8-16. PMID 12105827 DOI: 10.1053/Gast.2002.34232 |
0.273 |
|
| 2009 |
Shermock KM, Connor JT, Lavallee DC, Streiff MB. Clinical decision-making as the basis for assessing agreement between measures of the International Normalized Ratio Journal of Thrombosis and Haemostasis. 7: 87-93. PMID 19017256 DOI: 10.1111/J.1538-7836.2008.03225.X |
0.273 |
|
| 2013 |
Seal B, Asche C, Shermock K, Anderson S, Cameron J. Adherence Rates for Intravenous Chemotherapy Regimens to Treat Colon Cancer Value in Health. 16: A418. DOI: 10.1016/J.Jval.2013.08.548 |
0.273 |
|
| 2012 |
Shermock KM, Tandon S, Sorgen PJ, Lavallee DC, Clarke W, Streiff MB. Comparative performance of two methods that assess the quality of international normalized ratio measures. Clinical Biochemistry. 45: 530-4. PMID 22342920 DOI: 10.1016/J.Clinbiochem.2012.01.032 |
0.271 |
|
| 2011 |
Shermock KM, Lavallee DM, Streiff MB. Pmd36 Failure Of International Organization For Standardization Guidelines To Report Clinically Relevant Information About Point-Of-Care Inr Device Performance Value in Health. 14. DOI: 10.1016/J.Jval.2011.02.473 |
0.271 |
|
| 2002 |
Younossi ZM, Temple ME, Shermock KM. A pharmacoeconomic appraisal of therapies for hepatitis B and C. Expert Opinion On Pharmacotherapy. 2: 205-11. PMID 11336580 DOI: 10.1517/14656566.2.2.205 |
0.27 |
|
| 2016 |
Elder S, Hobson DB, Rand CS, Streiff MB, Haut ER, Efird LE, Kraus PS, Lehmann CU, Shermock KM. Hidden Barriers to Delivery of Pharmacological Venous Thromboembolism Prophylaxis: The Role of Nursing Beliefs and Practices. Journal of Patient Safety. 12: 63-8. PMID 24681420 DOI: 10.1097/Pts.0000000000000086 |
0.269 |
|
| 2008 |
Shermock K, Lavallee D, Connor J, Streiff M. Pcv96 The Effect Of Measurement Error From Point-Of-Care Inr Devices On Warfarin Dosing Decisions Value in Health. 11. DOI: 10.1016/S1098-3015(10)70682-3 |
0.268 |
|
| 2014 |
Efird LE, Golden SH, Visram K, Shermock K. Impact of a pharmacy-based glucose management program on glycemic control in an inpatient general medicine population. Hospital Practice (1995). 42: 101-8. PMID 24566602 DOI: 10.3810/Hp.2014.02.1097 |
0.266 |
|
| 2001 |
Shermock K, Vargo J, Zuccaro G, Maurer W. Pgi3: A Prospective, Randomized Cost Analysis Of Meperidine And Midazolam Versus Propofol For Complex Upper Endoscopy Procedures Value in Health. 4: 122. DOI: 10.1046/J.1524-4733.2001.40202-144.X |
0.266 |
|
| 2019 |
Aggarwal M, Jarrell A, Gilmore V, Aboagye J, Haut E, Hobson D, Lau B, Kickler T, Kraus P, Shaffer D, Shermock K, Streiff M, Zheng G, Kruer R. 954 Critical Care Medicine. 47: 455. DOI: 10.1097/01.Ccm.0000551702.30278.Ec |
0.265 |
|
| 2006 |
Shermock KM, Connor JT, Smith NT, Fink JM, Bragg L. Validity of criteria used to evaluate fingerstick devices that assess international normalized ratio. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 26: 239-46. PMID 16751322 DOI: 10.1177/0272989X06288681 |
0.264 |
|
| 2007 |
Bonomo RA, Van Zile PS, Li Q, Shermock KM, McCormick WG, Kohut B. Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective. Expert Review of Anti-Infective Therapy. 5: 773-82. PMID 17914912 DOI: 10.1586/14787210.5.5.773 |
0.264 |
|
| 2002 |
Shermock KM. Outcomes research in the health-care system: driven by results. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 5: 3-4. PMID 11873381 DOI: 10.1046/J.1524-4733.2002.51002.X |
0.264 |
|
| 2015 |
Seal B, Shermock K, Asche C, Kreilick C, Xia F, Kish J, Zagadailov E, Eaddy M. The Implications Of Using A 30-, 60-, Or 90-Day Gap In Treatment To Specify Lines Of Care In Gastric Cancer Treatment Value in Health. 18. DOI: 10.1016/J.Jval.2015.03.009 |
0.263 |
|
| 2010 |
Shermock K, Pinto B, Streiff M, Lavallee D. Pcv147 Novel Quality Assurance Analysis Reveals Previously Undetected Deficiencies In A Point Of Care Device That Measures The International Normalized Ratio Value in Health. 13. DOI: 10.1016/S1098-3015(10)72865-5 |
0.262 |
|
| 2013 |
Shermock KM, Lau BD, Haut ER, Hobson DB, Ganetsky VS, Kraus PS, Efird LE, Lehmann CU, Pinto BL, Ross PA, Streiff MB. Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies. Plos One. 8: e66311. PMID 23799091 DOI: 10.1016/J.Jval.2013.03.1509 |
0.259 |
|
| 2013 |
Seal B, Kreilick C, Boklage S, Shermock K, Gilmore J, Haislip S, Asche C. Treatment Patterns And Survival Benefit Of Second And Third Line Treatments In Colorectal Cancers – Georgia Cancer Specialist Database Value in Health. 16: A130. DOI: 10.1016/J.Jval.2013.03.633 |
0.256 |
|
| 2017 |
Shermock KM. Population health management: Challenges and opportunities for pharmacy. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 74: 1398-1399. PMID 28887339 DOI: 10.2146/Ajhp170530 |
0.251 |
|
| 2012 |
Valluri S, Seal B, Ramsey S, Sullivan SD, Shermock K, Sarma S, Kreilick C, Foltz-Boklage S. PCN11 Systemic Therapy for Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in Nationally Representative Claims Database in the United States Value in Health. 15. DOI: 10.1016/J.Jval.2012.03.1129 |
0.249 |
|
| 2013 |
Takemoto CM, Streiff MB, Shermock KM, Kraus PS, Chen J, Jani J, Kickler T. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring biochemical basis for discordance American Journal of Clinical Pathology. 139: 450-456. PMID 23525615 DOI: 10.1309/Ajcps6Ow6Dynognh |
0.247 |
|
| 2019 |
Merola D, Hill JD, Olumba S, Duncan R, Almuete V, Shermock KM. The Effect of Performance Transparency on Adherence to Barcode Scanning During Order Preparation in an Adult Inpatient Satellite Pharmacy. Hospital Pharmacy. 54: 37-44. PMID 30718933 DOI: 10.1177/0018578718764272 |
0.247 |
|
| 2003 |
Shermock K, Secic M, Fuller M, Dodd S. Pmh18: Retrospective Drug Use Evaluation Of Antipsychotic Agents In The Veterans Administration System:A Population Based Approach Value in Health. 6: 348-349. DOI: 10.1016/S1098-3015(10)64220-9 |
0.247 |
|
| 2020 |
Mooradian MJ, Shermock K, Merola D, Seal B, Yong C, Brannman L. HSR20-101: Real-World Chemoradiotherapy Use Among Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Retrospective Observational Study Journal of the National Comprehensive Cancer Network. 18: HSR20-101. DOI: 10.6004/Jnccn.2019.7488 |
0.245 |
|
| 1999 |
Singer M, Shermock K, Younossi Z. Id2: Chronic Hepatitis C: Cost-Effectiveness Of Interferon And Ribavirin Value in Health. 2: 134. DOI: 10.1016/S1098-3015(11)70838-5 |
0.245 |
|
| 2009 |
Shermock K, Pinto B, Streiff M. PCV28 THE CLINICAL IMPACT OF DIFFERENCES BETWEEN TWO MEASURES OF THE INTERNATIONAL NORMALIZED RATIO (INR) Value in Health. 12: A145. DOI: 10.1016/S1098-3015(10)73790-6 |
0.243 |
|
| 2013 |
Efird L, Shermock KM. Effect of A Pharmacy-Based Diabetes Management Program on Glycemic Control in an Inpatient General Medicine Population Value in Health. 17. PMID 27200713 DOI: 10.1016/J.Jval.2014.08.768 |
0.243 |
|
| 2010 |
Shermock KM, Connor JT, Lavallee DC, Streiff MB. Assessment of agreement between INR measures must correspond to a clinical reality. Clinica Chimica Acta; International Journal of Clinical Chemistry. 411: 1384-5; author reply. PMID 20478290 DOI: 10.1016/J.Cca.2010.05.019 |
0.243 |
|
| 2012 |
Seal B, Sullivan S, Ramsey S, Kreilick C, Foltz-Boklage S, Gilmore J, Haslip S, Asche C, Shermock K, Sarma S, Sun K. PCN17 Chemotherapy Treatment and Impact of Second Line Chemotherapy on Overall Survival (OS) in Metastatic Castrate Resistant Prostate Cancer (CRPC) in Southeastern Oncology Community Practice Value in Health. 15: A210. DOI: 10.1016/J.Jval.2012.03.1135 |
0.236 |
|
| 2013 |
Ensor CR, Walker CL, Rider SK, Clemente EU, Ashby DM, Shermock KM. Streamlining the process for initial review of pharmacy residency applications: an analytic approach. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 70: 1670-5. PMID 24048603 DOI: 10.2146/Ajhp120769 |
0.233 |
|
| 2023 |
Shermock SB, Shermock KM, Schepel LL. Closed-Loop Medication Management with an Electronic Health Record System in U.S. and Finnish Hospitals. International Journal of Environmental Research and Public Health. 20. PMID 37681820 DOI: 10.3390/ijerph20176680 |
0.232 |
|
| 2007 |
Dang D, Robert Feroli E, Gill C, Paine L, Shermock K, Suflita J, Walrath JM. Quest for the ideal: a redesign of the medication use system. Journal of Nursing Care Quality. 22: 11-7; quiz 18-9. PMID 17149079 DOI: 10.1097/00001786-200701000-00004 |
0.232 |
|
| 2011 |
Shermock KM, Shafir V, Streiff MB, Lavallee DM, Pinto BL, Haut E, Kraus P, Efird L, Elder S, Rand C. Pcv68 Factors Associated With Non-Administration Of Ordered Pharmacologic Venous Thromboembolism Prophylaxis Doses Value in Health. 14. DOI: 10.1016/J.Jval.2011.02.255 |
0.232 |
|
| 2014 |
Shermock KM, Ashby DM, Walker CL, Rider SK, Clemente EU, Ensor CR. Verifying information in pharmacy residency applications. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 71: 787. PMID 24780484 DOI: 10.2146/Ajhp130739 |
0.23 |
|
| 2015 |
Gibbs HG, Zimmerman DE, Shermock KM, Clarke W, Mirski MA, Lewin JJ. Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 72: 121-6. PMID 25550135 DOI: 10.2146/Ajhp140191 |
0.229 |
|
| 2020 |
Clark RRS, Warren N, Shermock KM, Perrin N, Lake E, Sharps PW. The Role of Oxytocin in Primary Cesarean Birth Among Low-Risk Women. Journal of Midwifery & Women's Health. PMID 32930507 DOI: 10.1111/Jmwh.13157 |
0.225 |
|
| 2002 |
Siatkosky LL, Shermock KM, Younossi ZM. Investigational pharmacologic treatment for liver disease. Expert Opinion On Investigational Drugs. 11: 1281-93. PMID 12225249 DOI: 10.1517/13543784.11.9.1281 |
0.213 |
|
| 2003 |
Shermock K, Connor J, Thomas N, Fink J, Bragg L. Pcvi: Validation Of Equations Used To Predict Warfarin Dosing Decisions Value in Health. 6: 306. DOI: 10.1016/S1098-3015(10)64116-2 |
0.212 |
|
| 2007 |
Szczesiul JM, Shermock KM, Murtaza UI, Siberry GK. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections. The Pediatric Infectious Disease Journal. 26: 852-4. PMID 17721387 DOI: 10.1097/Inf.0B013E318124Aa5C |
0.209 |
|
| 2002 |
Shermock K, Mchaourab A, Secic M, Schein J, Durkin M. Pnp4 Prescribing Patterns Of Long-Acting Opioids For Chronic Non-Malignant Pain In The Veterans Administration System Value in Health. 5: 271. DOI: 10.1016/S1098-3015(10)61172-2 |
0.206 |
|
| 2011 |
Goodwin H, Hinson HE, Shermock KM, Karanjia N, Lewin JJ. The use of lacosamide in refractory status epilepticus. Neurocritical Care. 14: 348-53. PMID 21249530 DOI: 10.1007/S12028-010-9501-8 |
0.205 |
|
| 2020 |
Saunders J, Proctor C, Shermock KM. A review of the United States' naming convention for biological products. Pharmacoepidemiology and Drug Safety. PMID 32319139 DOI: 10.1002/Pds.5003 |
0.199 |
|
| 2001 |
Shermock KM. Applying research ethics to quality-related initiatives. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 58: 1193. PMID 11449875 DOI: 10.1093/Ajhp/58.13.1193 |
0.195 |
|
| 2001 |
Leonard MC, Shermock KM. Using efficacy, safety, and cost data to support a formulary decision regarding thrombolytic therapy. Seminars in Vascular Surgery. 14: 150-5. PMID 11400091 DOI: 10.1053/SVAS.2001.23172 |
0.191 |
|
| 2004 |
Fink JM, Capozzi DL, Shermock KM, Militello MA, Hutson TE, Kalaycio ME, Bolwell BJ. Alteplase for central catheter clearance: 1 mg/mL versus 2 mg/2 mL. The Annals of Pharmacotherapy. 38: 351-2. PMID 14742778 DOI: 10.1345/Aph.1D004 |
0.184 |
|
| 2004 |
Broder J, Jerrard D, Olshaker J, Witting M, Hood R, Shermock KM, Emerman C. Littérature d'ailleurs : Les infections « des parties molles » - JP Stahl Medecine Et Maladies Infectieuses. 34: 273-280. DOI: 10.1016/J.Medmal.2004.04.001 |
0.176 |
|
| 2021 |
Tolonen HM, Falck J, Kurki P, Ruokoniemi P, Hämeen-Anttila K, Shermock KM, Airaksinen M. Is There Any Research Evidence Beyond Surveys and Opinion Polls on Automatic Substitution of Biological Medicines? A Systematic Review. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. PMID 34398421 DOI: 10.1007/s40259-021-00493-8 |
0.168 |
|
| 2021 |
Grucz TM, Crow J, Sugrue D, Davis S, Gager E, Beattie J, Shermock KM, Jarrell AS. Levocarnitine supplementation for management of hypertriglyceridemia in patients receiving parenteral nutrition. Nutrition in Clinical Practice : Official Publication of the American Society For Parenteral and Enteral Nutrition. PMID 34528297 DOI: 10.1002/ncp.10775 |
0.165 |
|
| 2003 |
Shrestha NK, Shermock KM, Gordon SM, Tuohy MJ, Wilson DA, Cwynar RE, Banbury MK, Longworth DL, Isada CM, Mawhorter SD, Procop GW. Predictive value and cost-effectiveness analysis of a rapid polymerase chain reaction for preoperative detection of nasal carriage of Staphylococcus aureus. Infection Control and Hospital Epidemiology. 24: 327-33. PMID 12785405 DOI: 10.1086/502219 |
0.15 |
|
| 1997 |
Barone JA, Shermock KM. Designer Drugs of Abuse Journal of Pharmacy Practice. 10: 292-300. DOI: 10.1177/089719009701000409 |
0.115 |
|
| 2021 |
Allan KA, Crow JR, Chasler JE, Athale J, Lindsley JP, Shermock KM, Streiff M, Whitman GJR, Dane KE. Comparison of Clinical Scoring Tools to Predict Heparin-Induced Thrombocytopenia in Cardiac Surgery. Seminars in Thoracic and Cardiovascular Surgery. PMID 34102291 DOI: 10.1053/j.semtcvs.2021.04.057 |
0.106 |
|
| 2018 |
Karas L, Shermock KM, Proctor C, Socal M, Anderson GF. Limited distribution networks stifle competition in the generic and biosimilar drug industries. The American Journal of Managed Care. 24: e122-e127. PMID 29668215 |
0.092 |
|
| 2020 |
Moore TJ, Mouslim MC, Blunt JL, Alexander GC, Shermock KM. Assessment of Availability, Clinical Testing, and US Food and Drug Administration Review of Biosimilar Biologic Products. Jama Internal Medicine. PMID 33031559 DOI: 10.1001/jamainternmed.2020.3997 |
0.09 |
|
| 2021 |
Dalpoas SE, Shermock KM. Practical utility of mixed methods research in pharmacy practice. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 34077491 DOI: 10.1093/ajhp/zxab232 |
0.074 |
|
| 2021 |
Crane MA, Shermock KM, Omer SB, Romley JA. Change in Reported Adherence to Nonpharmaceutical Interventions During the COVID-19 Pandemic, April-November 2020. Jama. PMID 33480971 DOI: 10.1001/jama.2021.0286 |
0.073 |
|
| 2015 |
Gibbs HG, Zimmerman DE, Shermock KM, Clarke W, Mirski MA, Lewin JJ. Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients American Journal of Health-System Pharmacy. 72: 121-126. DOI: 10.2146/ajhp140191 |
0.06 |
|
| 2021 |
Shermock KM. Budgeting in the post-COVID era: Be in the room where it happens. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 34297084 DOI: 10.1093/ajhp/zxab297 |
0.059 |
|
| 2013 |
Jeffers K, Scheel J, Vricella L, Shermock K, McNamara L, Ensor C. Non-Depleting Induction Immunosuppression Is Associated with Less Clinically Significant Acute Cellular Rejection in Pediatric Heart Transplantation Recipients The Journal of Heart and Lung Transplantation. 32: S241. DOI: 10.1016/j.healun.2013.01.619 |
0.052 |
|
| 2020 |
Dalpoas SE, Socal M, Proctor C, Shermock KM. Barriers to biosimilar utilization in the United States. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 33091103 DOI: 10.1093/ajhp/zxaa297 |
0.05 |
|
| 2022 |
Shermock KM. Corrigendum to: Budgeting in the post-COVID era: Be in the room where it happens. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 79: 600. PMID 35311892 DOI: 10.1093/ajhp/zxab307 |
0.027 |
|
| 2010 |
Ensor CR, Shermock KM. Proper analysis and interpretation of the stability of levothyroxine sodium 0.4 microg/mL in 0.9% sodium chloride injection. Progress in Transplantation (Aliso Viejo, Calif.). 20: 203, 208; author rep. PMID 20929103 |
0.023 |
|
| Hide low-probability matches. |